David Anderson
Hoofd Techniek/Wetenschap/O&O bij VBI VACCINES INC.
Vermogen: 2 959 $ op 30-04-2024
Actieve functies van David Anderson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VBI VACCINES INC. | Hoofd Techniek/Wetenschap/O&O | 06-05-2016 | - |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Hoofd Techniek/Wetenschap/O&O | 01-08-2015 | - |
Loopbaan van David Anderson
Eerdere bekende functies van David Anderson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Harvard Medical School | Corporate Officer/Principal | 01-01-2009 | 01-02-2009 |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Oprichter | - | - |
VBI VACCINES INC | Hoofd Techniek/Wetenschap/O&O | 25-07-2014 | - |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | - |
Oprichter | 01-01-2001 | - |
Opleiding van David Anderson
Harvard University | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Canada | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Health Technology |
- Beurs
- Insiders
- David Anderson
- Ervaring